-
If you think you are providing adequate information on intrauterine contraception during your reviews of birth control options, think again. Women are not getting the full message about this effective form of birth control.
-
You have just finished taking a medical history of an adolescent patient who has come in for contraceptive counseling. You have provided information on ways to prevent pregnancy and sexually transmitted diseases (STDs), and youve talked about the risks of being sexually active. But did your conversation specifically address oral sex?
-
Women who have been waiting for news of the Today contraceptive sponges re-emergence on U.S. market shelves can relax; the popular over-the-counter contraceptive should return to drugstore shelves this summer following the Food and Drug Administrations (FDAs) recent approval of the sponges manufacturing facility.
-
-
Nominations are being accepted for the Inspirations in Womens Health contest, sponsored by the Washington, DC-based National Association of Nurse Practitioners in Womens Health (NPWH) and the St. Paul, MN-based 3M Pharmaceuticals. The contest recognizes nurse practitioners who go above and beyond the call of duty in the areas of womens reproductive and sexual health.
-
The Bush administration and conservative members of Congress are touting legislation to create Association Health Plans (AHPs) as one of their answers to the growing problem of the nations uninsured, which totaled 45 million in 2003. These plans would allow professional and trade associations to band together to use their heightened purchasing power to offer insurance coverage to their members.
-
While trichomoniasis is the most common curable sexually transmitted disease (STD) in the United States,1 reports of metronidazole-resistant trichomoniasis are increasing. New evidence indicates that tinidazole (Tindamax, Presutti Laboratories, Rolling Meadows, IL), recently introduced in the United States, is an effective therapy for metronidazole-resistant trichomoniasis and is well tolerated even at high doses.
-
-
Entecavir is a nucleoside analog approved for the treatment of chronic hepatitis B viremia. It has demonstrated antiviral activity against both wild-type and lamivudine-resistant virus.
-
Celiac disease was found in 3.4% of patients with osteoporosis, compared to 0.2% without. Treatment with a gluten-free diet improved bone density scores. This study postulates that this prevalence justifies serologic screening for celiac disease in all patients with osteoporosis.